Physician profile
Nadav D Fields
NPI 1689010076
$3,177.84
in general payments reported to CMS, 2019-2025
20 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $456 · 2021: $514 · 2022: $371 · 2023: $112 · 2024: $519 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $386.52 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $377.41 | 2020-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $351.72 | 2019-2024 | |
| Abbott Laboratories | $347.87 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $255.82 | 2019-2024 | Xarelto |
| Merz North America, INC. | $198.81 | 2022-2023 | Xeomin |
| Pfizer INC. | $197.49 | 2019-2025 | |
| Abbvie INC. | $197.30 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $162.84 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $154.10 | 2019 | |
| Mylan Specialty L.P. | $114.03 | 2020 | |
| Galderma Laboratories, L.P. | $85.09 | 2024-2025 | Dysport |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.92 | 2019 | |
| Portola Pharmaceuticals, LLC | $64.33 | 2019 | |
| Boston Scientific Corporation | $56.31 | 2024-2025 | Farapulse, Watchman Flx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $39.38 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $34.47 | 2019 | |
| Csl Behring | $32.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.27 | 2019 | |
| Novo Nordisk INC | $19.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadav Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.